Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Research
Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Basic Sciences

Variation in the Binding of 125I-labeled Interferon-βser to Cellular Receptors during Growth of Human Renal and Bladder Carcinoma Cells in Vitro

Frank J. Ruzicka, Steven M. Schmid, Debra S. Groveman, Kenneth B. Cummings and Ernest C. Borden
Frank J. Ruzicka
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven M. Schmid
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Debra S. Groveman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth B. Cummings
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ernest C. Borden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published September 1987
  • Article
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: February 2001 to April 2021

AbstractFull-text HTMLPDF
Total5443488

Cited By

Article Information

Volume 47, Issue 17, pp. 4582-4589

PubMed 
2957045

Published By 
American Association for Cancer Research
Print ISSN 
0008-5472
Online ISSN 
1538-7445
History 
  • Received October 27, 1986
  • Revision received May 27, 1987
  • Accepted June 3, 1987
  • Published first September 1, 1987.

Copyright & Usage 
©1987 American Association for Cancer Research.

Author Information

  1. Frank J. Ruzicka,
  2. Steven M. Schmid2,
  3. Debra S. Groveman,
  4. Kenneth B. Cummings, and
  5. Ernest C. Borden3
  1. Departments of Human Oncology, Medicine and Surgery, University of Wisconsin Clinical Cancer Center, Madison, Wisconsin 53792
PreviousNext
Back to top
September 1987
Volume 47, Issue 17
  • Table of Contents
  • Table of Contents (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)

Sign up for alerts

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Variation in the Binding of 125I-labeled Interferon-βser to Cellular Receptors during Growth of Human Renal and Bladder Carcinoma Cells in Vitro
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Variation in the Binding of 125I-labeled Interferon-βser to Cellular Receptors during Growth of Human Renal and Bladder Carcinoma Cells in Vitro
Frank J. Ruzicka, Steven M. Schmid, Debra S. Groveman, Kenneth B. Cummings and Ernest C. Borden
Cancer Res September 1 1987 (47) (17) 4582-4589;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Variation in the Binding of 125I-labeled Interferon-βser to Cellular Receptors during Growth of Human Renal and Bladder Carcinoma Cells in Vitro
Frank J. Ruzicka, Steven M. Schmid, Debra S. Groveman, Kenneth B. Cummings and Ernest C. Borden
Cancer Res September 1 1987 (47) (17) 4582-4589;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

Basic Sciences

  • Glucocorticoid Insensitivity of P1798 Lymphoma Cells Is Associated with Production of a Factor That Attenuates the Lytic Response
  • Forestomach and Kidney Carcinogenicity of Caffeic Acid in F344 Rats and C57BL/6N × C3H/HeN F1 Mice
  • Immunohistochemical and Pharmacokinetic Characterization of Site-specific Immunoconjugate 15A8-Glycyl-tyrosyl-(N-ε-diethylenetriamine Pentaacetic Acid)-lysine Derived from Anti-Breast Carcinoma Monoclonal Antibody 15A8
Show more Basic Sciences

Articles

  • Glucocorticoid Insensitivity of P1798 Lymphoma Cells Is Associated with Production of a Factor That Attenuates the Lytic Response
  • Forestomach and Kidney Carcinogenicity of Caffeic Acid in F344 Rats and C57BL/6N × C3H/HeN F1 Mice
  • Immunohistochemical and Pharmacokinetic Characterization of Site-specific Immunoconjugate 15A8-Glycyl-tyrosyl-(N-ε-diethylenetriamine Pentaacetic Acid)-lysine Derived from Anti-Breast Carcinoma Monoclonal Antibody 15A8
Show more Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement